Ignite Creation Date:
2025-12-26 @ 10:18 PM
Ignite Modification Date:
2026-01-03 @ 4:36 AM
Study NCT ID:
NCT02124512
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2014-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Blood Lipopolysaccharide (LPS) Rifaximin Study
Sponsor:
Philip Kern
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03
Start Date Type:
None
Primary Completion Date:
2019-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-23
First Submit QC Date:
None
Study First Post Date:
2014-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-16
Results First Submit QC Date:
None
Results First Post Date:
2019-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-06
Last Update Post Date:
2019-08-21
Last Update Post Date Type:
ACTUAL